Apogee Therapeutics, Inc. (APGE)

135.06 +0.08 (+0.06%) USD  |  NASDAQ  |  Aug 31, 16:00
135.06 0.00 (0.00%) After-Hours: 18:40
More

Apogee Therapeutics Cash from Operations (Annual) : -227.45M for Dec. 31, 2025

Cash from Operations (Annual) Chart

View Cash from Operations (Annual) for APGE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Annual) Chart
Start Trial

Historical Cash from Operations (Annual) Data

View and export this data back to 2022. Start Trial.
Date Value
December 31, 2025 -227.45M
December 31, 2024 -171.17M
Date Value
December 31, 2023 -74.76M
December 31, 2022 -16.43M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Cogent Biosciences, Inc. -264.44M
Arrowhead Pharmaceuticals, Inc. 179.55M
Intellia Therapeutics, Inc. -394.74M
Revolution Medicines, Inc. -897.74M
Erasca, Inc. -95.46M